JNJ

238.73

+0.41%↑

UNH

276.85

-1.14%↓

TMO

547.18

+0.58%↑

ABT

112.59

+1.5%↑

ISRG

497.45

+1.18%↑

JNJ

238.73

+0.41%↑

UNH

276.85

-1.14%↓

TMO

547.18

+0.58%↑

ABT

112.59

+1.5%↑

ISRG

497.45

+1.18%↑

JNJ

238.73

+0.41%↑

UNH

276.85

-1.14%↓

TMO

547.18

+0.58%↑

ABT

112.59

+1.5%↑

ISRG

497.45

+1.18%↑

JNJ

238.73

+0.41%↑

UNH

276.85

-1.14%↓

TMO

547.18

+0.58%↑

ABT

112.59

+1.5%↑

ISRG

497.45

+1.18%↑

JNJ

238.73

+0.41%↑

UNH

276.85

-1.14%↓

TMO

547.18

+0.58%↑

ABT

112.59

+1.5%↑

ISRG

497.45

+1.18%↑

Search

Phreesia Inc

Atidarymo kaina

SektoriusSveikatos priežiūra

12.68 4.02

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

12.1

Max

12.72

Pagrindiniai rodikliai

By Trading Economics

Pajamos

3.6M

4.3M

Pardavimai

3.1M

120M

Pelno marža

3.549

Darbuotojai

2,082

EBITDA

6.1M

13M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+130.33% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-11

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-409M

796M

Ankstesnė atidarymo kaina

8.66

Ankstesnė uždarymo kaina

12.68

Naujienos nuotaikos

By Acuity

48%

52%

139 / 352 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

Phreesia Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-02-09 17:25; UTC

Įsigijimai, susijungimai, perėmimai

Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion -- Update

2026-02-09 23:46; UTC

Rinkos pokalbiai

Nikkei May Rise on Hopes for Domestic Policy Measures -- Market Talk

2026-02-09 23:43; UTC

Rinkos pokalbiai

Gold Falls on Possible Technical Correction -- Market Talk

2026-02-09 23:14; UTC

Rinkos pokalbiai

WiseTech's Bull Reckons AI-Driven Selloff Is Overdone -- Market Talk

2026-02-09 22:29; UTC

Rinkos pokalbiai

Australian Coking Coal Price Seen Falling Once Supply Disruptions Ease -- Market Talk

2026-02-09 22:19; UTC

Rinkos pokalbiai

Pro Medicus's Business Case Made More Compelling by AI Adoption -- Market Talk

2026-02-09 22:08; UTC

Rinkos pokalbiai

Minerals 260 Bull Bets on Production Scale, Takeover Appeal -- Market Talk

2026-02-09 22:01; UTC

Uždarbis

Friedman Industries Sees 4Q Sales Volume to Generally Consistent With 3Q, With Sequential Improvement in Sales Margins

2026-02-09 21:59; UTC

Uždarbis

Friedman Industries: Hedging Activities Continued to Perform as Anticipated by Mitigating Impact of Commodity Price Volatility

2026-02-09 21:59; UTC

Uždarbis

Friedman Industries: Average Selling Prices Began to Improve as Quarter Progressed

2026-02-09 21:58; UTC

Uždarbis

Friedman Industries 3Q Sales $168M >FRD

2026-02-09 21:50; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-02-09 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-09 21:48; UTC

Uždarbis

Friedman Industries 3Q EPS 43c >FRD

2026-02-09 21:17; UTC

Uždarbis

Kyndryl Stock Drops 55%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

2026-02-09 21:13; UTC

Rinkos pokalbiai

U.S. Ethanol Crush Margins Near Break-Even -- Market Talk

2026-02-09 21:04; UTC

Uždarbis

Retail Sales Data Should Confirm a Robust Holiday Season -- Barrons.com

2026-02-09 20:30; UTC

Rinkos pokalbiai

Oil Futures Gain As U.S.-Iran Risk Premium Holds -- Market Talk

2026-02-09 20:02; UTC

Rinkos pokalbiai

U.S. Natural Gas Falls on Warmer Weather Outlook -- Market Talk

2026-02-09 19:42; UTC

Rinkos pokalbiai

Japan's Yield Curve Expected to Flatten -- Market Talk

2026-02-09 19:31; UTC

Rinkos pokalbiai

Nike Seen Regaining Relevance With Consumers -- Market Talk

2026-02-09 19:27; UTC

Rinkos pokalbiai

Gold Climbs Back Over $5,000/oz -- Market Talk

2026-02-09 19:05; UTC

Rinkos pokalbiai

Nike Returns to List of Hottest Brands -- Market Talk

2026-02-09 18:19; UTC

Rinkos pokalbiai

Lower Dollar Doesn't Translate to Boost in Grains -- Market Talk

2026-02-09 17:41; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, AppLovin, Monday.com, Valaris, and More -- Barrons.com

2026-02-09 17:31; UTC

Uždarbis
Įsigijimai, susijungimai, perėmimai

These Stocks Are Today's Movers: Kyndryl, Hims & Hers, Novo Nordisk, Monday.com, Valaris, Cleveland-Cliffs, and More -- Barrons.com

2026-02-09 17:20; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Financial Services Roundup: Market Talk

2026-02-09 17:20; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-02-09 17:17; UTC

Rinkos pokalbiai

Century Aluminum Announces Next Steps of Okla. Project -- Market Talk

2026-02-09 17:16; UTC

Uždarbis

Kyndryl Stock Drops 56%. It's So Much Worse Than an Earnings Miss. -- Barrons.com

Akcijų palyginimas

Kainos pokytis

Phreesia Inc Prognozė

Kainos tikslas

By TipRanks

130.33% į viršų

12 mėnesių prognozė

Vidutinis 28.1 USD  130.33%

Aukščiausias 35 USD

Žemiausias 22 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Phreesia Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

12 ratings

12

Pirkti

0

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

25.23 / 25.61Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Neutral Evidence

Vidutinės trukmės periodas

Strong Bullish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

139 / 352 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Phreesia Inc

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
help-icon Live chat